Alnylam Pharmaceuticals (ALNY) Stock: Buy, Sell, or Hold?
$165.04
+8.39 (+5.36%)
▲
5d:
+5.84%
30d:
-29.48%
90d:
-26.52%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 29, 2026
0d
Protect ALNY Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
60/100
Position
OVERSOLD
30-Day Fair Range
$167.12 – $233.83
Position: OVERSOLD
Forward P/E & Valuation
15.2x
CHEAP
vs 23.4x historical avg
Wall Street Target
$299.96
+81.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$149.18 / $170.49
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: ALNY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When ALNY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$52.98
Based on -24.2% avg growth
INTRINSIC VALUE TODAY
$32.90
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALNY is currently trading at $165.04, which is considered oversold relative to its 30-day fair value range of $167.12 to $233.83. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.2) compared to its historical average (23.4). Remarkably, the market is currently pricing in an annual earnings decline of 13.3% over the next few years. This pessimistic expectation contrasts with the company's recent 633.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ALNY is in a strong downtrend. Immediate support is located at $149.18, while resistance sits at $170.49. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: ALNY scores 93/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $299.96 (+81.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALNY is in a strong downtrend. Immediate support is located at $149.18, while resistance sits at $170.49. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: ALNY scores 93/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $299.96 (+81.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$167.12 -
$233.83
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
Trading Range & Key Levels
30-Day Trading Range
$167.12 -
$233.83
Current vs Trading Range
OVERSOLD
Support Level
$149.18
Resistance Level
$170.49
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding ALNY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (93/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- BULLISH: Trading 81.8% below Wall St target ($299.96)
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
15.24
Wall Street Target
$299.96
(+81.8%)
Revenue Growth (YoY)
16.7%
Earnings Growth (YoY)
633.5%
Profit Margin
52.8%
Valuation Discount vs History
-13.3% cheaper
PE vs Historical
15.2 vs 23.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.3%
(market-implied from PE analysis)
1-Year Target
$148.54
(-10%)
2-Year Target
$133.68
(-19%)
3-Year Target
$120.31
(-27%)
3-Yr Target (if PE normalizes)
(PE: 15→23)
$184.77
(+12%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -52.3%)
$156.81
(+-5%)
Base:
(SPY PE: 15.2, Growth: -52.3%)
$120.31
(-27%)
Bear:
(PE: 13.0, Growth: -52.3%)
$102.27
(-38%)
📈
Valuation based on Current Earnings
Trailing PE: 7.91 | Current EPS (TTM): $19.80
Bull Case
$94.26
(-43%)
Analyst growth -45.3%, PE expands to 8.7
Base Case
$85.69
(-48%)
Market implied -45.3%, PE stable at 7.9
Bear Case
$106.52
(-36%)
Severe decline -20.0%, PE contracts to 6.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.2 to 23.4
Stabilization Target:
$253.45
(+53.6%)
PE Expansion Potential:
+53.6%
Share ALNY Analysis
Share this live ALNY analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ALNY)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 8, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment prevails on StockTwits regarding $ALNY's $1B buyback announcement, with critics questioning the timing given the company's $1B in convertible debt.
Key Retail Themes:
Buyback decisions
Debt management
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 5:46 AM ET
Data refreshes hourly during market hours. Next update: 6:46 AM
Data refreshes hourly during market hours. Next update: 6:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALNY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 33 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 30 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 35 SELL |
Advanced ALNY Option Strategies
Professional options setups generated by AI based on today's ALNY price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ALNY Research Pages
